Learn More
MDR-1339, MedChemExpress
MedChemExpress MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.
Brand: Medchem Express HY-14503

Description
MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.Specifications
MDR-1339 | |
White | |
C20H22O4 | |
DWK-1339 | |
COCCCC1=CC=C(OC(C2=CC=C(OC)C(OC)=C2)=C3)C3=C1 | |
326.39 | |
Research | |
Neuroscience-Neurodegeneration |
1018946-38-7 | |
Research | |
25 mg | |
DMSO : 50 mg/mL (153.19 mM; Need ultrasonic) | |
326.39 | |
98.03% | |
Solid |
Product Suggestions
Customers who viewed this item also viewed
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Research purposes only